about
Recommendations for the Management of Herpes ZosterCohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) studyComparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface areaEffects of music-based therapy on distress following knee arthroplasty.Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) studyDevelopment of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly IndividualsEvidence of GnRH antagonist escape in obese women.Treatment considerations for elderly and frail patients with neuropathic painCriteria for drug selection in frail elderly persons.Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.Bladder cancer in the elderly.Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairmentPopulation pharmacokinetics of mavacoxib in osteoarthritic dogs.Association of skeletal muscle relaxers and antihistamines on mortality, hospitalizations, and emergency department visits in elderly patients: a nationwide retrospective cohort studyClinical pharmacology relevant to older adults with cardiovascular disease.Effects of aging on mRNA profiles for drug-metabolizing enzymes and transporters in livers of male and female miceAcute coronary syndromes: an old age problem.Prevalence of drug interactions in elderly patients with multimorbidity in primary care.BCRP protein levels do not differ regionally in adult human livers, but decline in the elderly.Health outcomes associated with potentially inappropriate medication use in older adults.Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer.The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers.Pharmacological treatment of neuropathic pain in older persons.Atorvastatin and cardiovascular risk in the elderly--patient considerationsClinical pharmacokinetics of antiretroviral drugs in older persons.Medications in the kidney.Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections.Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants?Prescribing for older adults.Pharmacokinetic considerations for digoxin in older people.Clinical pharmacokinetics and pharmacodynamics of vildagliptin.Medication-related falls in the elderly: causative factors and preventive strategies.Medication prescribing in frail older people.Practical Management of Anaesthesia in the Elderly.Interprofessional learning on polypharmacy.Evidence-based information leads to reduction in inappropriate drug prescribing: Results from Indian older inpatients.Pharmacokinetics of Vancomycin in Elderly Patients Aged over 80 Years.Impact of Rosuvastatin in Contrast-Induced Acute Kidney Injury in the Elderly: Post Hoc Analysis of the PRATO-ACS Trial.Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart SurveyAdverse drug reactions as the cause of emergency department admission: focus on the elderly.
P2860
Q28315869-3AF8E05F-0DBB-4565-BB60-E91919CF88A2Q28384359-85F80828-CC12-4348-B7CD-8F6AAC8D42B8Q28752593-87B70DD4-56CA-47F4-ABFD-661C71858B1BQ30355451-DEC582AE-7DDF-40CC-A388-C6DD3BE73661Q30661806-3E33C814-03AA-4557-ACF1-DD5D41884D57Q30828459-C500D126-0B69-44A3-80D7-DF9B73D3A138Q33569055-687710AC-2F88-4C53-BB41-58CBDC0470A0Q33747265-D9EF3C68-C5A4-4899-ABC7-CDD3569E848CQ33889859-5645C972-F621-4BCF-AE0D-14F6A5E1E508Q34100187-50776298-C8CB-4F33-8765-0477080C017BQ34479053-B72B18DD-4285-42F1-990D-DA7BEB7B3DDAQ34608990-6364F377-7C11-4203-AB01-854481C6C42BQ34626223-C685C0EF-F80D-4441-AAFA-A1787A6EDB73Q35065993-7A721FA7-4F53-4CED-A45B-96E4561CA760Q35697301-E61D8230-FBDF-4DDC-9C5E-F82EF0A922FCQ35996427-80E98671-E201-4073-8D10-6F129E60F0A7Q36166356-072BF866-E9D0-42C1-8034-76095DE8716EQ36290903-C43952DA-E3C1-4EA6-B779-DF44F45F1305Q36414807-F71898E9-15D6-4A9B-B06B-5850BA305CC6Q36468166-3598A318-89AF-44F0-93E4-E8A4C3FD60FEQ36506987-6E84DF4B-5D84-4236-92B9-4A34629A9FD9Q36535937-41C0F894-9243-4D70-B712-3D9109AD56B0Q36892837-B07C84F8-1B9F-4A69-B5B6-D4200C5BCC1FQ36897445-FAE22B6A-4CBF-4E3E-A2B7-4F9FA1DDCCD0Q36905884-E9DE4F52-BD6F-4C31-A5CC-E934E1B0F73BQ37198832-61ADFFB7-5923-4F19-B50E-3DA3C8CBC8F3Q37298388-22FEE2B4-F57A-43BE-BA23-8DD750A52174Q37445634-ECB58A9B-A231-4178-9DAD-9AC7CEDF46DAQ37900254-58695979-40ED-4348-B3AA-8FB600FD5BABQ37902523-59DCA1C3-9CEF-4A87-904A-88FA47181CB5Q37984567-2F014358-C93E-42E9-8EA9-530EA1D14E69Q38006976-3DE255CD-D5A6-4558-B674-FC23ABD6DBD1Q38042383-0EB418E8-D630-4896-9956-BFA7CB504C14Q38995371-A8C58AAA-94E6-464A-9787-5AFDB88676FAQ40028242-41D2F2C3-FC83-4AB2-9F62-261B57ACF3F3Q40117848-D427A7D7-FEAA-4FE6-82B4-03773DE004FAQ40672214-A0131EB8-F308-496A-901E-500BD45B18DCQ41452418-9819C32F-FCE1-482C-803B-7DD5274E6F6FQ42640060-FB9FC940-672A-4E99-80A0-03C18306B648Q43185920-71734FE6-D258-4C5D-B13A-A0715F426AD5
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacokinetics in older persons.
@ast
Pharmacokinetics in older persons.
@en
type
label
Pharmacokinetics in older persons.
@ast
Pharmacokinetics in older persons.
@en
prefLabel
Pharmacokinetics in older persons.
@ast
Pharmacokinetics in older persons.
@en
P1476
Pharmacokinetics in older persons.
@en
P2093
Barry J Cusack
P304
P356
10.1016/J.AMJOPHARM.2004.12.005
P577
2004-12-01T00:00:00Z